Good post. One of the initial problems is the level of discussion we came from. Which was little to nothing. The bashers would make the same charges over and over and over for years day in and day out. The resposible posters, who either wanted to post reliable info or just have a good discussion, were drowned out by the bashers. If we hadn't found this site, I doubt hardly anyone would be posting today. The bashers mostly set the ground rules on the other board. Just say something often enough and get other bashers to agree with you and it must be true. Like they've been saying for over two years this company is going bankrupt. Well, you say the sky is falling for long enough and nobody pays you attention anymore. Which brings us to today. What is a discussion? Two people having a conversation. One person makes a statement or asks a question. Someone else responds. Typically, a basher does not want to answer questions. He only wants to refute something you said. I honestly don't think some peoples questions are asked but for the sole reason to make a point. As I've been reading today, I thought, Wer, you are a brave soul to open this can. Is it possible to have a discussion? Yes and no. With some yes, with others no. I like the idea though. Not only for here but for future stocks. And for those posters who you do not wish to engage, there is always the ignore button. Good for you, Wer, and your efforts to bring us out of the playpen. My best to all, Jim
Good post. One of the initial problems is the level of
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Zenas BioPharma Investors Urged to Join Class Action Lawsuit
Overview of the Class Action Lawsuit Levi & Korsinsky, LLP is reaching out to investors in Zenas BioPharma, Inc. regarding a crucial class action lawsuit. This lawsuit may greatly impact those who have invested in Zenas BioPharma as it seeks to compensate individuals who have suffered losses due to alleged securities fraud. Understanding the Legal Landscape This class...
Continue Reading
Ayar Labs Raises $155 Million to Transform AI Infrastructure
Ayar Labs Secures Significant Funding to Enhance AI Infrastructure Ayar Labs has recently secured $155 million in financing aimed at addressing the critical needs in AI infrastructure. With backing from prominent investors such as AMD Ventures, Intel Capital, and NVIDIA, alongside Advent Global Opportunities and Light Street Capital, this investment elevates the total...
Continue Reading
Transforming the Non-Profit Sector: The Impact Collaborative
Impact Collaborative Launches to Transform the Non-Profit Sector Today marks a significant milestone with the launch of the Impact Collaborative (IC), a pioneering initiative aimed at revolutionizing the support provided to under-resourced communities. This innovative approach seeks to disrupt generational poverty while offering much-needed access to mental health and...
Continue Reading
Synovus Financial Corp Declares Quarterly Dividends for Investors
Synovus Financial Corp Declares Quarterly Dividends Synovus Financial Corp. (NYSE: SNV) has recently revealed the details of its latest quarterly dividends. The board of directors has approved significant payouts to its shareholders, reinforcing the company’s ongoing commitment to deliver value to its investors. Details of the Declared Dividends The following dividends...
Continue Reading
Walnut Hill Medical Enhances Patient Access Through FDA TAP Program
Walnut Hill Medical Partners with FDA in TAP Program Walnut Hill Medical, a prominent healthcare consultancy known for its market access and reimbursement strategies, has been chosen as an advisor to the FDA's Total Product Life Cycle Advisory Program (TAP). This initiative, which originated from the FDA's Center for Devices and Radiological Health (CDRH), aims to improve...
Continue Reading